PillRx only · Tablet · Oral
Prochlorperazine Maleate
Prochlorperazine Maleate
21 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US39 NDCs
21 active makers
21 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 15 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.141
Latest avg · Jul 22, 2026
-19%
Since Dec 17, 2025
21
Active US suppliers
28%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
90K
Rx · 2026 Q1
3.4M
Units dispensed
+35%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it21 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Sportpharm LLC | unknown | 10 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 9 | SUPPLYING |
| Proficient Rx LP | unknown | 8 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 4 | SUPPLYING |
| Jubilant Cadista Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | unknown | 4 | SUPPLYING |
| Bionpharma Inc. | unknown | 4 | SUPPLYING |
| Northwind Health Company, LLC | unknown | 3 | SUPPLYING |
| Redpharm Drug | unknown | 3 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| Major Pharmaceuticals | unknown | 2 | SUPPLYING |
| AvPAK | unknown | 2 | SUPPLYING |
| Ajanta Pharma USA Inc. | unknown | 2 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 2 | SUPPLYING |
| A-S Medication Solutions | unknown | 2 | SUPPLYING |
+ 6 more labelers
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Dec 27, 2022RECALLRecall (Class III): Prochlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, Mar…
Subpotent Drug: Out of specification for assay at the 18-month stability timepoint. — Recalling firm: Jubilant Cadista Pharmaceuticals, Inc. — Nationwide in the USA.